News
Explore the latest news and material from across our business
![](https://yaqrit.com/wp-content/uploads/2021/06/1656a.png)
7th Jan 2021
Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
![](https://yaqrit.com/wp-content/uploads/2020/08/image-news-tile-aliver-1.jpg)
7th Jan 2021
The ALIVER Consortium announces positive results from Phase 2 equivalent trial of the novel liver dialysis device, Dialive™
![](https://yaqrit.com/wp-content/uploads/2021/01/carbalive_1140x682.png)
7th Jan 2021
The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis
![](https://yaqrit.com/wp-content/uploads/2020/08/image-news-tile-aliver-1.jpg)
27th Aug 2020
Yaqrit as part of the ALIVER Consortium announces completion of first randomised controlled study of DIALIVE
![](https://yaqrit.com/wp-content/uploads/2017/04/image-news-tile-9.jpg)